CTLA4 and neoplasm: The complementary roles of PD-1 and CTLA-4 in immune response regulation (through the processes of preventing T cell depletion and promoting T cell activation, respectively) indicate that bispecific antibodies could enhance the functionality of tumour-infiltrating T cells when compared to anti-CTLA-4 or PD-L1 antibodies alone [37].